CD8A and lung carcinoma: Prado-Garcia et al. showed that in MPEs from primary lung cancer, the percentage of CD8+ T cells, in particular, the terminally differentiated subset, was reduced compared to non-malignant effusions because they underwent antibody-induced cell death31.